Seascape Capital Management Astrazeneca PLC Transaction History

Seascape Capital Management

$349 Million
Q3 2025

A detailed history of Seascape Capital Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Seascape Capital Management holds 47,750 shares of AZN stock, worth $4.27 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares

47,750

Previous 42,619 12.04%

Holding current value

$4.27 Million

Previous $2.98 Million 23.0%

% of portfolio

1.05%

Previous 0.94%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	BUY	$68.72 - $82.11 $352,602 - $421,306	5,131 Added 12.04%	47,750 $3.66 Million
Q2 2025 Jul 14, 2025	SELL	$64.87 - $75.0 $17,450 - $20,175	-269 Reduced 0.63%	42,619 $2.98 Million
Q1 2025 Apr 29, 2025	BUY	$65.37 - $77.96 $37,849 - $45,138	579 Added 1.37%	42,888 $3.15 Million
Q4 2024 Jan 30, 2025	BUY	$63.2 - $79.58 $65,222 - $82,126	1,032 Added 2.5%	42,309 $2.77 Million
Q3 2024 Nov 01, 2024	SELL	$76.67 - $87.62 $115,465 - $131,955	-1,506 Reduced 3.52%	41,277 $3.22 Million

Q2 2024 Jul 30, 2024	BUY	$66.81 - $80.83 $8,551 - $10,346	128 Added 0.3%	42,783 $3.34 Million
Q1 2024 Apr 29, 2024	BUY	$61.03 - $69.57 $41,805 - $47,655	685 Added 1.63%	42,655 $2.89 Million
Q4 2023 Jan 29, 2024	BUY	$61.89 - $69.28 $111,649 - $124,981	1,804 Added 4.49%	41,970 $2.83 Million
Q3 2023 Nov 09, 2023	SELL	$64.85 - $71.7 $6,031 - $6,668	-93 Reduced 0.23%	40,166 $2.72 Million
Q2 2023 Aug 04, 2023	SELL	$69.91 - $75.81 $94,867 - $102,874	-1,357 Reduced 3.26%	40,259 $2.88 Million
Q1 2023 May 01, 2023	SELL	$63.15 - $71.6 $288,406 - $326,997	-4,567 Reduced 9.89%	41,616 $2.89 Million
Q4 2022 Jan 31, 2023	BUY	$54.21 - $70.44 $39,519 - $51,350	729 Added 1.6%	46,183 $3.13 Million
Q3 2022 Nov 08, 2022	SELL	$53.02 - $135.75 $15,375 - $39,367	-290 Reduced 0.63%	45,454 $2.49 Million
Q2 2022 Aug 09, 2022	BUY	$59.26 - $71.14 $10,963 - $13,160	185 Added 0.41%	45,744 $3.02 Million
Q1 2022 May 09, 2022	BUY	$55.72 - $67.12 $78,398 - $94,437	1,407 Added 3.19%	45,559 $3.02 Million
Q4 2021 Jan 27, 2022	BUY	$54.02 - $63.83 $49,374 - $58,340	914 Added 2.11%	44,152 $2.57 Million
Q3 2021 Nov 05, 2021	BUY	$55.56 - $60.79 $541,543 - $592,520	9,747 Added 29.1%	43,238 $2.6 Million
Q2 2021 Aug 04, 2021	BUY	$48.42 - $60.18 $120,711 - $150,028	2,493 Added 7.44%	35,984 $2.16 Million
Q2 2021 Aug 04, 2021	SELL	$48.42 - $60.18 $120,711 - $150,028	-2,493 Reduced 6.93%	33,491 $1.67 Million
Q1 2021 Apr 29, 2021	BUY	$47.16 - $54.44 $206,089 - $237,902	4,370 Added 15.01%	33,491 $1.67 Million
Q4 2020 Jan 28, 2021	SELL	$48.52 - $58.02 $71,372 - $85,347	-1,471 Reduced 4.81%	29,121 $1.46 Million
Q3 2020 Nov 09, 2020	BUY	$53.07 - $61.1 $46,064 - $53,034	868 Added 2.92%	30,592 $1.68 Million
Q2 2020 Aug 11, 2020	BUY	$43.1 - $55.31 $1.28 Million - $1.64 Million	29,724 New	29,724 $1.57 Million
Q1 2020 May 28, 2020	SELL	$37.79 - $51.33 $1.21 Million - $1.64 Million	-31,899 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $1.35 Million - $1.61 Million	31,899 New	31,899 $1.59 Million

Others Institutions Holding AZN

# of Institutions

1,498

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seascape Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Seascape Capital Management with notifications on news.

Account

Seascape Capital Management Astrazeneca PLC Transaction History